hrcak mascot   Srce   HID

Ostalo

Topical 5% benzoyl peroxide and 3% erythromycin gel: Experience from 191 patients with inflammatory acne

Efstathios Andreas Rallis ; Veterans Administration Hospital (NIMTS), Department of Dermatology
Constantinos Verros
Alexandros Katoulis
Alexandra Katsarou

Puni tekst: engleski, PDF (307 KB) str. 160-160 preuzimanja: 720* citiraj
APA 6th Edition
Andreas Rallis, E., Verros, C., Katoulis, A. i Katsarou, A. (2013). Topical 5% benzoyl peroxide and 3% erythromycin gel: Experience from 191 patients with inflammatory acne. Acta Dermatovenerologica Croatica, 21 (3), 160-160. Preuzeto s https://hrcak.srce.hr/109922
MLA 8th Edition
Andreas Rallis, Efstathios, et al. "Topical 5% benzoyl peroxide and 3% erythromycin gel: Experience from 191 patients with inflammatory acne." Acta Dermatovenerologica Croatica, vol. 21, br. 3, 2013, str. 160-160. https://hrcak.srce.hr/109922. Citirano 08.12.2021.
Chicago 17th Edition
Andreas Rallis, Efstathios, Constantinos Verros, Alexandros Katoulis i Alexandra Katsarou. "Topical 5% benzoyl peroxide and 3% erythromycin gel: Experience from 191 patients with inflammatory acne." Acta Dermatovenerologica Croatica 21, br. 3 (2013): 160-160. https://hrcak.srce.hr/109922
Harvard
Andreas Rallis, E., et al. (2013). 'Topical 5% benzoyl peroxide and 3% erythromycin gel: Experience from 191 patients with inflammatory acne', Acta Dermatovenerologica Croatica, 21(3), str. 160-160. Preuzeto s: https://hrcak.srce.hr/109922 (Datum pristupa: 08.12.2021.)
Vancouver
Andreas Rallis E, Verros C, Katoulis A, Katsarou A. Topical 5% benzoyl peroxide and 3% erythromycin gel: Experience from 191 patients with inflammatory acne. Acta Dermatovenerol Croat. [Internet]. 2013 [pristupljeno 08.12.2021.];21(3):160-160. Dostupno na: https://hrcak.srce.hr/109922
IEEE
E. Andreas Rallis, C. Verros, A. Katoulis i A. Katsarou, "Topical 5% benzoyl peroxide and 3% erythromycin gel: Experience from 191 patients with inflammatory acne", Acta Dermatovenerologica Croatica, vol.21, br. 3, str. 160-160, 2013. [Online]. Dostupno na: https://hrcak.srce.hr/109922. [Citirano: 08.12.2021.]

Sažetak
Background. A dramatic increase in bacterial resistance as a result of the use of topical antibiotics in acne has been recorded over the past 20 years.
Aim. In this study we investigated the efficacy and safety of the topical treatment with 5% benzoyl peroxide and 3% erythromycin gel in patients with inflammatory acne.
Materials and Methods. One hundred and ninety one patients with inflammatory acne were evaluated. The patients included 54 males and 137 females with a mean average age being 22.3±8.1 years. The topical gel was applied on the face, once daily, for 3 months.
Results. The mean number of non-inflammatory and inflammatory decreased. These findings were statistically significant from baseline with a mean percentage reduction of the non-inflammatory and inflammatory lesions, corresponding to 42.2% and 57.5% respectively.
Conclusion. Topical 5% benzoyl peroxide and erythromycin 3% as monotherapy is efficient in the treatment of inflammatory acne.

Ključne riječi
Acne; inflammatory; treatment; topical treatment; 5% benzoyl peroxide gel; erythromycin 3% gel; antibiotics

Hrčak ID: 109922

URI
https://hrcak.srce.hr/109922

Posjeta: 1.095 *